Related Experiment Video
Updated: Aug 4, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis
J McCarty1, J A Hedrick, W M Gooch
1Valley Children's Hospital, Madera, California 93638, USA.
Insights
Clarithromycin, an antibiotic, effectively treated streptococcal pharyngitis in children, showing superior eradication of group A beta-hemolytic streptococcus (GABHS) compared to penicillin V. A 5-day clarithromycin course proved more effective than 10-day penicillin.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Clarithromycin exhibits potent in vitro activity against group A beta-hemolytic streptococcus (GABHS).
- Its favorable pharmacokinetic profile suggests suitability for treating streptococcal pharyngitis.
- Penicillin V is a standard treatment for GABHS infections.
Purpose of the Study:
- To compare the safety and efficacy of clarithromycin and penicillin V in treating streptococcal pharyngitis in children.
- To evaluate GABHS eradication rates between the two antibiotic regimens.
Main Methods:
- A randomized, investigator-blind study compared 5-day clarithromycin suspension to 10-day penicillin V suspension in children aged 6 months to 12 years.
- Clinical assessments and throat cultures were performed before, during, and after therapy.
- Efficacy endpoints included clinical success and GABHS eradication rates.
Main Results:
- Clarithromycin and penicillin V demonstrated comparable clinical success rates (97% vs. 94% post-treatment; 81% vs. 82% follow-up).
- Clarithromycin achieved a significantly higher GABHS eradication rate (94% vs. 78%, P < .001).
- Both treatments were well-tolerated with mild gastrointestinal complaints; no resistance emerged.
Conclusions:
- A 5-day course of clarithromycin is superior to a 10-day course of penicillin V for eradicating Streptococcus pyogenes.
- Clarithromycin offers an effective and well-tolerated alternative for pediatric streptococcal pharyngitis treatment.
Abstract:
Clarithromycin, an advanced-generation macrolide antibiotic, has demonstrated excellent in vitro activity against group A beta-hemolytic streptococcus (GABHS). Potent activity against Streptococcus pyogenes and a favorable pharmacokinetic profile have made it a reasonable alternative for treatment of patients with streptococcal pharyngitis. The safety and efficacy of clarithromycin and penicillin V were compared in a randomized, investigator-blind study. Children 6 months to 12 years of age received 5 days of clarithromycin suspension 7.5 mg/kg twice daily (n = 268) or 10 days of penicillin V suspension 13.3 mg/kg three times daily (n = 260). Patients were evaluated for signs and symptoms of pharyngitis, and throat swabs for culture were obtained prior to therapy, at the end of therapy, and at follow-up. Clarithromycin and penicillin V produced comparable rates of clinical success (cure + improvement) at the posttreatment (97% and 94%) and follow-up (81% and 82%) evaluations. The GABHS eradication rate, however, was significantly higher with clarithromycin (94% vs 78%, P < .001). Both drugs were well tolerated; gastrointestinal complaints were similar and mild. Resistance did not occur with the short course of clarithromycin or the standard regimen of penicillin V. Five days' treatment with clarithromycin was superior to 10 days of penicillin in eradicating S. pyogenes.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Production of Antibiotics
Streptococcal Pharyngitis